Literature DB >> 16549727

Topical recombinant alpha1-antitrypsin: a potential treatment for Netherton syndrome?

Juliette Mazereeuw-Hautier, Judith Cope, Christina Ong, Adrian Green, Alain Hovnanian, John I Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16549727     DOI： 10.1001/archderm.142.3.396

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  The Delivery of α1-Antitrypsin Therapy Through Transepidermal Route: Worthwhile to Explore.

Authors:  Srinu Tumpara; Beatriz Martinez-Delgado; Gema Gomez-Mariano; Bin Liu; David S DeLuca; Elena Korenbaum; Danny Jonigk; Frank Jugert; Florian M Wurm; Maria J Wurm; Tobias Welte; Sabina Janciauskiene
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

Review 2.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 3.  New developments in the molecular treatment of ichthyosis: review of the literature.

Authors:  M D W Joosten; J M K Clabbers; N Jonca; J Mazereeuw-Hautier; A H Gostyński
Journal:  Orphanet J Rare Dis       Date:  2022-07-15       Impact factor: 4.303

Review 4.  Abnormal skin barrier in the etiopathogenesis of atopic dermatitis.

Authors:  Peter M Elias; Matthias Schmuth
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10

Review 5.  Netherton Syndrome in Children: Management and Future Perspectives.

Authors:  Federica Barbati; Mattia Giovannini; Teresa Oranges; Lorenzo Lodi; Simona Barni; Elio Novembre; Ermanno Baldo; Mario Cristofolini; Stefano Stagi; Silvia Ricci; Francesca Mori; Cesare Filippeschi; Chiara Azzari; Giuseppe Indolfi
Journal:  Front Pediatr       Date:  2021-05-10       Impact factor: 3.418
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.